An Outcome Assessment of a Single Institution’s Longitudinal Experience with Uveal Melanoma Patients with Liver Metastasis

There is no FDA-approved treatment for metastatic uveal melanoma (UM) and overall outcomes are generally poor for those who develop liver metastasis. We performed a retrospective single-institution chart review on consecutive series of UM patients with liver metastasis who were treated at Thomas Jef...

Descripción completa

Detalles Bibliográficos
Autores principales: Seedor, Rino S., Eschelman, David J., Gonsalves, Carin F., Adamo, Robert D., Orloff, Marlana, Amjad, Anjum, Sharpe-Mills, Erin, Chervoneva, Inna, Shields, Carol L., Shields, Jerry A., Mastrangelo, Michael J., Sato, Takami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016993/
https://www.ncbi.nlm.nih.gov/pubmed/31906411
http://dx.doi.org/10.3390/cancers12010117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7016993/
https://www.ncbi.nlm.nih.gov/pubmed/31906411
http://dx.doi.org/10.3390/cancers12010117

Ejemplares similares